ZPJ-13396-23247
2 vaccinations
4 coded responses
13 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 921 / CA
- Registered
- 2020-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-15
Registered in v-safe
-
2020-12-15
Dose 1 — Pfizer-BioNTech
- 2020-12-15
-
2020-12-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-17
- 2020-12-18
- 2020-12-19
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-22
- 2020-12-29
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-05
Survey response — day 21, dose 1MedDRA: Myalgia, Nasal congestion — Feeling: FairFree text: Muscle pain, nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-20
-
2021-04-06
Survey response — 3 months, dose 2MedDRA: Thrombophlebitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Superficial thrombophlebitis of RUEMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-18
Call successfulParticipant prefers to complete VAERS report online
- 2022-01-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-06 | Successful 2021-05-18 |
Participant prefers to complete VAERS report online |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose
Systemic reaction (other): Sore throat
Release 1 — day 21, dose 1
Symptoms: Muscle pain, nasal congestion
Release 7 — 3 months, dose 2
Symptoms: Superficial thrombophlebitis of RUE
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Thrombophlebitis | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release